ROSEANN VELEZ: Open Payments
NPI 1831103977 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$181 in 2 payments from 2 companies in 2025. Trend: 2023 $549 · 2024 $453 · 2025 $181
Food & beverage: $181
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $122 |
| Axsome Therapeutics, Inc. | 1 | $59 |
Products named: FASENRA, Auvelity.
Industry payments across MD — which companies pay providers there.
